(TCRR) –
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form 15-12G TCR2 THERAPEUTICS INC.
-
Form EFFECT TCR2 THERAPEUTICS INC.
-
Form EFFECT TCR2 THERAPEUTICS INC.
-
Form EFFECT TCR2 THERAPEUTICS INC.
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: UBS Oncology Impact Fund L.P.
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: MPM SunStates Fund GP LLC
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: GADICKE ANSBERT
-
Form POS AM TCR2 THERAPEUTICS INC.
-
Form POS AM TCR2 THERAPEUTICS INC.
-
Form POS AM TCR2 THERAPEUTICS INC.
-
Form S-8 POS TCR2 THERAPEUTICS INC.
-
Form S-8 POS TCR2 THERAPEUTICS INC.
-
Form S-8 POS TCR2 THERAPEUTICS INC.
-
Form S-8 POS TCR2 THERAPEUTICS INC.
-
Form S-8 POS TCR2 THERAPEUTICS INC.
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Allen Andrew R
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Tomasello Shawn
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Sullivan Eric
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Cardama Alfonso Quintas
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Olagunju Peter
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Webster Stephen W
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Harrison Rosemary
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Menzel Garry E
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Justice Angela
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Hoos Axel
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Hegde Priti
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: Gibson Neil W
-
Form 8-K TCR2 THERAPEUTICS INC. For: Jun 01
-
Adaptimmune Announces Completion of Strategic Combination with TCR2 Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
-
Form 25-NSE TCR2 THERAPEUTICS INC. Filed by: Nasdaq Stock Market LLC
-
Form 4 TCR2 THERAPEUTICS INC. For: May 25 Filed by: TANG KEVIN C
-
Form 425 TCR2 THERAPEUTICS INC. Filed by: Adaptimmune Therapeutics PLC
-
Form 8-K TCR2 THERAPEUTICS INC. For: May 30
-
Form DEFA14A TCR2 THERAPEUTICS INC.
-
Form 425 TCR2 THERAPEUTICS INC. Filed by: TCR2 THERAPEUTICS INC.
-
Form 8-K TCR2 THERAPEUTICS INC. For: May 23
-
Form 4 TCR2 THERAPEUTICS INC. For: May 22 Filed by: GADICKE ANSBERT
-
Form 4 TCR2 THERAPEUTICS INC. For: May 22 Filed by: EVNIN LUKE
-
Form DEFA14A TCR2 THERAPEUTICS INC.
-
Form 425 TCR2 THERAPEUTICS INC. Filed by: TCR2 THERAPEUTICS INC.
-
Form 8-K TCR2 THERAPEUTICS INC. For: May 22
-
Form 4 TCR2 THERAPEUTICS INC. For: May 11 Filed by: TANG CAPITAL PARTNERS LP
-
TCR2 Therapeutics (TCRR) PT Raised to $2.11 at Mizuho Securities
-
TCR2 Therapeutics (TCRR) Misses Q1 EPS by 26c
-
Form 10-Q TCR2 THERAPEUTICS INC. For: Mar 31
-
Form 8-K TCR2 THERAPEUTICS INC. For: May 11
-
TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Form 4 TCR2 THERAPEUTICS INC. For: May 08 Filed by: TANG CAPITAL PARTNERS LP
Back to TCRR Stock Lookup